Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

A nutrient deficiency occurs when your body doesn’t get enough of a particular nutrient, whether that’s essential vitamins or ...

Serenity may feel hard to come by these days, but the natural world still offers solace for those willing to seek it.

Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

The US will rebuild a stockpile of avian influenza vaccines for poultry that match the strain of the virus circulating in commercial flocks and wild birds, Reuters reported, citing the Department of ...

The U.S. will rebuild a stockpile of bird flu vaccines for poultry that match the strain of the virus circulating in commercial flocks and wild birds, the Department of Agriculture said on Wednesday, ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of ...

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies.

The stock's fall snapped a two-day winning streak.